Novan Advances Women’s Health Business Unit with Non-Dilutive Funding
August 14, 2019 08:15 ET
|
Novan, Inc.
Company has received NIH federal grant of approximately $223,000Anticipates additional federal grant of approximately $1.0 millionWomen’s health initiative to focus on potential HPV related onco-virus...
Novan Takes Steps to Reduce Real Estate Footprint
August 13, 2019 16:15 ET
|
Novan, Inc.
Company entered into negotiations with third party to transfer lease obligationNon-binding letter of intent signed60-day exclusivity period to finalize detailsA successful transaction would lead to a...
Novan’s Phase 3 Molluscum Pivotal Program Completes Enrollment
August 13, 2019 08:15 ET
|
Novan, Inc.
MORRISVILLE, N.C., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company has recently completed patient recruitment in the Company’s...
Novan’s Drug Substance Demonstrates Inhibition of HPV-18 Virus Production
July 24, 2019 08:30 ET
|
Novan, Inc.
Preclinical data published in Antiviral ResearchStudy conducted by Drs. N.S. Banerjee, L.T. Chow and T.R. Broker at The University of Alabama at BirminghamFindings reinforce anti-viral mechanism of...
Novan Expands External Business Partner Network
June 19, 2019 08:15 ET
|
Novan, Inc.
Expansion of the existing relationship with MedPharm around formulation scienceManufacturing agreement established for production of proprietary drug substancePartner network now includes those...
Novan to Participate in JMP Securities Life Sciences Conference
June 13, 2019 09:15 ET
|
Novan, Inc.
MORRISVILLE, N.C., June 13, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that it will participate in the 2019 JMP Securities Life Sciences Conference...
Novan Achieves Compliance with Nasdaq Listing Rule 5450(b)(2)(A)
June 06, 2019 16:15 ET
|
Novan, Inc.
MORRISVILLE, N.C., June 06, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN) today announced it has received notification from The Nasdaq Stock Market LLC ("Nasdaq")...
First Patient Enrolled and Dosed in Novan’s SB206 Phase 3 Molluscum Program
June 04, 2019 06:30 ET
|
Novan, Inc.
Phase 3 pivotal program commences and underwayInvestigative sites now activated and enrollment activities actionedAnticipated patient demand managed with a highly disciplined approach to trial...
Novan Announces 2019 Annual Meeting of Stockholders for July 31, 2019
May 31, 2019 16:15 ET
|
Novan, Inc.
MORRISVILLE, N.C., May 31, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN) today announced that it will hold its 2019 Annual Meeting of Stockholders on Wednesday, July...
Novan to Present Clinical Data at Annual Meeting of the Society for Investigative Dermatology
May 07, 2019 16:15 ET
|
Novan, Inc.
MORRISVILLE, N.C., May 07, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that recent data from the Company’s Phase 1b trial with SB414 cream for the...